Botanical species · safety record

Spiraea cantoniensis

The EFSA Compendium of Botanicals holds 1 adverse-effect record for Spiraea cantoniensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Spiraea cantoniensis Lour.

0Constituent measurements
1Safety records
1Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Plant parts

  • Flower1

Preparations

  • Solvent extraction1

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveFlowerSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yoshida, Kaori., Hishida, Atsuyuki., Iida, Osamu., Hosokawa, Keizo., Kawabata, Jun. Flavonol caffeoylglycosides as alpha-glucosidase inhibitors from Spiraea cantoniensis flower . Journal of agricultural and food chemistry, 2008, vol. 56, no. 12, p. 4367-4371. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue